Background Sudden cardiac death among children and young adults is a devastating event.
We performed a prospective, population-based, clinical and genetic study of sudden …

Objectives : The aim of this study was to describe the clinical profile associated with triple
sarcomere gene mutations in a large hypertrophic cardiomyopathy (HCM) cohort. Background : …

Large whales are subjected to a variety of conservation pressures that could be better
monitored and managed if physiological information could be gathered readily from free-…

Objectives : This study describes a genome-wide linkage analysis of a large family with
clinically heterogeneous hypertrophic cardiomyopathy (HCM). Background : Familial HCM is a …

Background— Yield of causative variants in hypertrophic cardiomyopathy (HCM) is
increased in some probands, suggesting different clinical subgroups of disease occur. We …

As the smallest and one of the most recently evolved marine mammals, sea otters face
physiological challenges rarely encountered by larger, more derived aquatic species. To examine …

Purpose Genetic testing for hypertrophic cardiomyopathy has been commercially available
for almost a decade; however, low mutation detection rate and cost have hindered uptake. …

Patients with hypertrophic cardiomyopathy (HC) are reported to have a mortality rate of about
1.0% per year, and those patients without sudden death risk factors and with no or mild …

While the inherited cardiomyopathies and primary arrhythmogenic disorders are distinctly
different diseases, the genetic counseling issues can be very similar. 14 Collectively, these …

Hypertrophic cardiomyopathy (HC), a common genetic heart disorder associated with
substantial clinical and genetic heterogeneity, is the most frequent cause of sudden death in the …